Human medicines European public assessment report (EPAR): Kayfanda, odevixibat, Date of authorisation: 19/09/2024, Revision: 2, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 8 May 2025 - 8:45

Human medicines European public assessment report (EPAR): Kayfanda, odevixibat, Date of authorisation: 19/09/2024, Revision: 2, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/kayfanda

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters